SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-024258
Filing Date
2023-05-25
Accepted
2023-05-25 16:30:52
Documents
12
Period of Report
2023-05-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K dyn-20230524.htm   iXBRL 8-K 86238
  Complete submission text file 0000950170-23-024258.txt   211448

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dyn-20230524.xsd EX-101.SCH 2468
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dyn-20230524_pre.xml EX-101.PRE 11112
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dyn-20230524_lab.xml EX-101.LAB 17770
6 EXTRACTED XBRL INSTANCE DOCUMENT dyn-20230524_htm.xml XML 4697
Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39509 | Film No.: 23961206
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences